P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-alpha and promotes hyperplasia in mammary

Rui-An Wang1, Abhijit Mazumdar, Ratna K Vadlamudi

  • 1Department of Molecular and Cellular Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

The EMBO Journal
|October 11, 2002
PubMed

Insights

p21-activated kinase-1 (Pak1) promotes mammary gland hyperplasia by activating the estrogen receptor-alpha (ER). Pak1 directly phosphorylates ER, enhancing its transactivation functions and leading to epithelial overgrowth.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Cancer Research

Background:

  • p21-activated kinase-1 (Pak1) is implicated in cytoskeleton organization and signaling in cancer cells.
  • Estrogen receptor-alpha (ER) is a key regulator of mammary gland development and function.

Purpose of the Study:

  • To investigate the role of Pak1 in mammary gland development and ER signaling.
  • To elucidate the molecular mechanisms by which Pak1 influences ER activity.

Main Methods:

  • Inhibition of Pak1 using dominant-negative fragments and short interference RNA.
  • Development of a transgenic murine model with constitutively active Pak1.
  • Analysis of mammary gland morphology, ER transactivation, and downstream gene expression.
  • Site-directed mutagenesis to study Pak1 phosphorylation of ER at Ser305.

Main Results:

  • Pak1 inhibition reduced ER transactivation functions.
  • Constitutively active Pak1 in murine mammary glands led to hyperplasia, apocrine metaplasia, and hyperdevelopment.
  • Active Pak1 increased mitogen-activated protein kinase activation and ER target gene expression.
  • Pak1 directly phosphorylated ER at Ser305, a modification crucial for ER transactivation.

Conclusions:

  • Pak1 plays a significant role in mammary gland hyperplasia.
  • The Pak1-ER signaling pathway is a novel mechanism regulating mammary epithelial proliferation.
  • Pak1-mediated phosphorylation of ER at Ser305 is a key event in promoting ER activity and mammary gland overgrowth.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...